Pulmonary Thromboses in Pediatric Acute Respiratory Distress Syndrome

Magalie Caudron1, Tanya Holt2, Geoff DE Cuvelier3

  • 1Division of Pediatric Critical Care, University of British Columbia, Vancouver, British Columbia, Canada.

Respiratory Care
|December 26, 2018
PubMed

Insights

Pulmonary thrombosis is an underrecognized complication in pediatric acute respiratory distress syndrome (ARDS). A proposed diagnostic algorithm and early heparin treatment may improve outcomes for these critically ill children.

Area of Science:

  • Critical Care Medicine
  • Pediatric Pulmonology
  • Hematology

Background:

  • Pediatric acute respiratory distress syndrome (ARDS) presents significant management challenges, including prolonged hospital stays and high mortality rates.
  • Thromboembolic pulmonary embolism and in situ pulmonary artery thrombosis are potentially underappreciated thrombotic complications in pediatric ARDS.
  • While risk factors like coagulopathy and endothelial injury are common in pediatric ARDS, pulmonary thromboses are primarily described in case reports.

Purpose of the Study:

  • To propose a diagnostic algorithm for early identification of pulmonary thromboses in pediatric ARDS patients.
  • To suggest a management strategy involving targeted heparin treatment and right ventricular afterload reduction.
  • To improve clinical outcomes by identifying and treating this specific patient subgroup.

Main Methods:

  • Development of a diagnostic algorithm triggered by specific physiological parameters: alveolar dead space fraction ≥ 0.25, a 50% increase in dead space/tidal volume, or central venous saturation ≤ 60% over 24 hours.
  • Interpretation of data from animal, pediatric, and adult studies to inform the algorithm's development.
  • Consideration of targeted heparin treatment and right ventricular afterload reduction as therapeutic interventions.

Main Results:

  • The proposed algorithm aims to facilitate timely and accurate diagnosis of pulmonary thromboses in pediatric ARDS.
  • Early identification and intervention may lead to improved clinical outcomes.
  • Data on anticoagulation efficacy and safety in children with pulmonary embolism are limited compared to adults.

Conclusions:

  • Pulmonary thromboses may be an underdiagnosed cause of morbidity and mortality in pediatric ARDS.
  • The proposed diagnostic algorithm and treatment strategy offer a potential pathway to improve patient care.
  • Further research is needed to validate the algorithm and establish optimal anticoagulation protocols for pediatric ARDS patients with pulmonary thrombosis.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
502
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
990
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
882
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
564